glp-1 semaglutide and tirzepatide Troubling Findings in Study of Compounders combining semaglutide and tirzepatide title

Russo SC, Ockene MW, Arpante AK, et al

The silver lining is that March and April are typically the wettest months of the year, and theres still time for Mother Nature to come through for us, she said.

Clinical studies show that lower doses of GLP-1 agonists are highly effective at reducing hemoglobin A1c (which indicates the average blood sugar level over the past 2-3 months), improving insulin sensitivity, and directly addressing the metabolic dysregulation often associated with estrogen decline and perimenopausal weight gain, helping to stabilize energy levels and reduce fat-storage signaling

As an alarming finding, the activation of GLP-1R has been associated with developing thyroid cancer [64, 65]